What are the main growth drivers of the veterinary pharmaceuticals market and how are they split between companion animals and livestock?
The veterinary pharmaceuticals market is driven by rising animal health spending, increasing pet ownership and the industrialization of livestock farming. The companion animal segment (dogs, cats) generates high value through chronic treatments, vaccines and preventive care, while livestock is dominated by mass vaccination, antiparasitics and anti-infectives aimed at productivity and biosecurity. Sectorious reports help compare these dynamics, identify high-growth regions and assess the impact of regulations on antibiotic use and veterinary treatments.